New for 2018!
North America and the US are leading the charge when it comes to innovations in biopharmaceuticals. So it stands to reason that CPhI North America serves as a global platform for converging small and large molecule markets by offering a one-stop-pharma-shop for companies to source for their requirements on manufacturing and processing. With 50% of surveyed 2017 buyers onsite looking to meet new suppliers in the Bio-sphere, CPhI North America 2018 is your time to establish your presence in the North American market.
Biopharmaceuticals currently generate global revenues of $162 billion.
The Biopharmaceutical market is projected to grow at CAGR 9.4% in 2017-2021, reaching $278 billion by 2021.
Biomanufacturers will be spending more on innovation, increasing their budgets an expected 6% for new technologies.
Outsourcing of biopharmaceutical manufacturing will continue to increase as companies aim to increase testing services and production efficiencies.
CPhI North America 2017 at a Glance
We know that professionals in bio prefer events where they can meet other biopharma companies— from universities with renowned R&D programs to big pharma’s biologic and biosimilars to regulators. So we specifically-created the new-for-2018 Bioprocessing Zone to give biopharma professionals a space to meet all the people, companies, and suppliers to conquer some of their biggest challenges.
Do Business Better
CPhI North America offers you a unique platform to meet your peers, clients and prospects face-to-face. Don’t miss the chance to connect with a qualified group of relevant buyers looking for new products, suppliers and services.
- 80% of attendees have a role in the purchasing cycle
- 68 % of attendees said they were likely to do business with one or more exhibiting company
- 48% of attendees were new to CPhI events
Attendees visit the show with a singular focus: to find the latest innovations in machinery, equipment, and technology.
“It was wonderful. Well organized, great range of companies represented. My company and I made a lot of promising connections”
- Marketing / Communications / PR, Other: Multi disciplines-BioTech, Pharmaceutical, USA
It is the best opportunity for the members in global pharmaceutical market regarding find a new strategy and build up the new idea in all the value-chain.
- Sales, Pharmaceutical Company (generic finished products), South Korea
2017 Attendees Included...
Associate Director, Scientific Affairs - Sandoz
Associate Director, Strategic Sourcing – Novartis
Biochemist - Siemens
Buyer - Adesis, Inc
Category Manager Global Procurement - Bristol Myers Squibb
Director, CMO Business - Sanofi
Director, Global Procurement - Pfizer
Director, Procurement - MilliporeSigma
Director, Procurement & Supplier Quality – Fujifilm
Director, Purchasing & Supplier Management – AbbVie
Director, Research - Baxter Healthcare
Director, Science & Technology - Catalent
Global Category Buyer - BASF
Global Category Leader - GSK
Head, Topical Formulation and Process Development - GSK
Manager, Facility & Procurement - Adesis, Inc
Manager, Strategic Sourcing - Johnson & Johnson
R&D Procurement - Johnson & Johnson
Research Scientist - Bayer
Senior Formulation Scientist - GSK
Senior Scientist - Bristol Myers Squibb
Senior Scientist - GSK
Senior Sourcing Manager - Bristol Myers Squibb
Sourcing Manager - Sanofi
Vice President, R&D Technology - Johnson & Johnson
Products & Services Found in the Bioprocessing Zone
Academia and Research Centres | Analytical Chemistry | Analytical Methods | Antibodies | Bio Clusters | Bio process technologies | Bioelectronics | Bioinformatics | Biopharmaceuticals | Biotechnology and related specialities | Bio-similar | Cell biology | Diagnostics | Genomics & Proteomics | Immunology | Medicinal chemistry | Molecular Biology | Platform technologies | Process validation | Protein chemistry | Technology and software | Tissue Culture Medias | Toxicology / virology